Latest 8-K filings

Bandwidth Inc. presented an investor deck on September 15, 2026, detailing its position as a global cloud communications leader with a focus on AI-driven interactions and significant market expansion.

First Bancorp announced a cash dividend of $0.24 per share, payable on October 23, 2026, underscoring its commitment to shareholder returns amidst stable financial performance.

Tredegar Corporation announces the appointment of Cindy Yao as its new Vice President, Chief Financial Officer, and Treasurer, effective September 21, 2026.

Innventure, Inc. reports that senior management and directors have agreed to forfeit 435,168 common shares previously issued as earnouts related to an Accelsius purchase order from Dark NX.

Origin Bancorp, Inc. announced its decision to voluntarily transfer its common stock listing from the New York Stock Exchange to the Texas Stock Exchange, effective October 13, 2026.

5E Advanced Materials, Inc. announced it has entered into an agreement to acquire critical mineral production facilities, brine resources, and related infrastructure from Searles Valley Minerals through a court-supervised bankruptcy sale process.

Cabot Corporation announced the appointment of Steven J. Delahunt as interim Chief Financial Officer, effective October 1, 2026, as the company continues its search for a permanent successor.

GT Biopharma, Inc. has entered into a Securities Purchase Agreement for the private placement of Series M Convertible Preferred Stock and Warrants, raising $7.45 million.

Pulse Biosciences announced the completion of patient enrollment in its PRECISE-BTN clinical study for symptomatic benign thyroid nodules, with the first patient also completing 12-month follow-up.

PBF Energy's subsidiary, PBF Holding Company LLC, has priced a $500 million private offering of 0% senior unsecured exchangeable notes due 2032, with an option for an additional $50 million.

Catalyst Bancorp, Inc. has entered into new three-year employment agreements with its Chief Operations Officer and Chief Financial Officer, detailing salaries and severance packages.

Astrana Health, Inc. updated its corporate presentation, showcasing robust growth in value-based care members, revenue, and raising its FY2026 Adjusted EBITDA guidance.

OMNIQ Corp. has been granted a U.S. patent for its AI-based vehicle occupancy detection system, poised to enhance HOV lane enforcement and tap into a substantial market.

Summit Therapeutics announced updated overall survival results from its global Phase III HARMONi clinical trial, demonstrating consistent efficacy with ivonescimab plus chemotherapy.

The Scotts Miracle-Gro Company announced the redemption of $250 million in senior notes, renewal of its A/R facility, and commencement of a $500 million share repurchase program, while reaffirming its Fiscal 2026 financial guidance.

BioMarin Pharmaceutical Inc. announced the discontinuation of VOXZOGO development for children with Noonan syndrome, citing feasibility and treatment landscape factors.

Scholar Rock Holding Corporation clarifies FDA post-marketing requirements for ISEMBYLD after an earlier misstatement during an investor call.

Evommune, Inc. shared an updated corporate presentation detailing advancements in its novel therapeutic candidates for chronic inflammation, alongside a robust cash runway extending into 2029.

USA TODAY Co., Inc. announced the appointment of Tim Allen, CEO of Babbel, to its Board of Directors, effective September 15, 2026, to bolster digital innovation and growth strategies.

AGNT, Inc. has completed a substantial repurchase of 8,693,290 shares of its common stock for $31,991,307.20, accelerating its capital return program.

Aethlon Medical, Inc. has amended employment agreements for its CEO/CFO and Chief Medical Officer to provide for lump-sum severance and healthcare continuation payments in the event of a Change in Control.

Otis Worldwide Corporation announced that CEO Judy Marks will retire in 2027 as part of a long-standing succession plan, with a search for her successor already initiated.

Coya Therapeutics announced the enrollment of the 100th patient in its Phase 2/3 ALSTARS trial for amyotrophic lateral sclerosis (ALS), with topline data anticipated in early Q2 2027.

Intrusion Inc. and CEO Anthony Scott have agreed not to automatically renew his employment contract, entering a negotiation period for new terms.

Vera Bradley announced second quarter fiscal year 2027 results, showing a 1.1% increase in consolidated net revenues to $71.6 million and an 8.0% rise in direct segment sales.

Corteva, Inc. has officially approved the separation of its seed operating segment into a new independent company, Vylor Inc., with a distribution date set for October 1, 2026.

Corteva, Inc. has officially approved the separation of its seed operating segment into a new independent company, Vylor Inc., with a distribution date set for October 1, 2026.

RB Global announced an increase in its share repurchase program from $500 million to $1 billion, receiving approval from the Toronto Stock Exchange.

LB Pharmaceuticals Inc. announced the appointment of Dr. Susan G. Kozauer as its new Chief Medical Officer, effective September 14, 2026, bringing extensive experience in neuropsychiatric drug development.

NextTrip's travel media platform, JOURNY TV, is set to premiere its first original series, 'I DO: In Destination,' on October 4-5, 2026, integrating travel content with booking capabilities.